Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases  Xiaoyu Hu, Lionel B. Ivashkiv  Immunity 

Slides:



Advertisements
Similar presentations
Control of Th2-Mediated Inflammation by Regulatory T Cells
Advertisements

Nat. Rev. Rheumatol. doi: /nrrheum
Laurent L'homme, PhD, David Dombrowicz, PhD 
Amit Awasthi, Vijay K. Kuchroo  Immunity 
CD5: A New Partner for IL-6
Bugs and Brain: How Infection Makes You Feel Blue
The Leptin Connection: Regulatory T Cells and Autoimmunity
Notch: Filling a Hole in T Helper 2 Cell Differentiation
Figure 2 Molecular pathways involved in the regulation of T-cell differentiation and cytokine production Figure 2 | Molecular pathways involved in the.
Malaria Vaccine Design: Immunological Considerations
Nicholas van Bruggen, Wenjun Ouyang  Immunity 
Keratins and the Keratinocyte Activation Cycle
Boosting the Brain's Ability to Block Inflammation via MicroRNA-132
Methed-Up FOXOs Can't In-Akt-ivate
Unraveling the Pros and Cons of Interferon-γ Gene Regulation
Bhagelu Ram Achyut, Li Yang  Gastroenterology 
Kaitlin A. Read, Michael D. Powell, Paul W. McDonald, Kenneth J
Metabolic control of regulatory T cell development and function
ER stress-induced inflammation: does it aid or impede disease progression?  Abhishek D. Garg, Agnieszka Kaczmarek, Olga Krysko, Peter Vandenabeele, Dmitri.
Foxo1 and Foxo3 help Foxp3 Immunity
Janus Kinase Deregulation in Leukemia and Lymphoma
Reciprocal regulation between hepcidin and erythropoiesis and its therapeutic application in erythroid disorders  Caiyi Wang, Zheng Fang, Zesen Zhu, Jing.
A New Twist in Smad Signaling
Wei Liao, Jian-Xin Lin, Warren J. Leonard  Immunity 
Volume 26, Issue 3, Pages (March 2007)
Figure 4 Mechanisms of leptin function on kidney injury
Dietmar M.W. Zaiss, William C. Gause, Lisa C. Osborne, David Artis 
BTLA+ Dendritic Cells: The Regulatory T Cell Force Awakens
Alternative Activation of Macrophages: Mechanism and Functions
Tilo Biedermann, Martin Röcken, José M. Carballido 
Selective Insulin and Leptin Resistance in Metabolic Disorders
T Cells Are Smad’ly in Love with Galectin-9
The RAS/MAPK Axis Gets Stressed Out
Long Noncoding RNA in Hematopoiesis and Immunity
Summon SUMO to Wrestle with Inflammation
Macrophages in Tissue Repair, Regeneration, and Fibrosis
p38δ and PKD1: Kinase Switches for Insulin Secretion
SHIP, SHIP2, and PTEN activities are regulated in vivo by modulation of their protein levels: SHIP is up-regulated in macrophages and mast cells by lipopolysaccharide 
SRC and STAT Pathways Journal of Thoracic Oncology
Volume 123, Issue 6, Pages (December 2002)
Wenjun Ouyang, Anne O’Garra  Immunity 
SOCS Proteins, Regulators of Intracellular Signaling
Regulation of the Immune Response by the Aryl Hydrocarbon Receptor
Schematic summary of the mechanisms by which tick-borne Phlebovirus NSs proteins inhibit the canonical IFN induction and signaling pathways. Schematic.
Advances in Hypoxia-Inducible Factor Biology
Genetic Control of MHC Class II Expression
Tobias R. Kollmann, Ofer Levy, Ruth R. Montgomery, Stanislas Goriely 
Volume 28, Issue 6, Pages (June 2008)
Volume 39, Issue 3, Pages (September 2013)
Driving Rel-iant Tregs toward an Identity Crisis
Figure 4 Bile-acid-induced TGR5 signalling pathways in macrophages
Cigarette Smoke Resets the Alarmin IL-33 in COPD
IL-22 from T Cells: Better Late than Never
Cytokine Signaling Modules in Inflammatory Responses
Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
Shared Principles in NF-κB Signaling
Regulatory T Cells in Asthma
Treating myocardial ischemia-reperfusion injury by targeting endothelial cell transcription  Edward M Boyle, MD, Timothy G Canty, MD, Elizabeth N Morgan,
Khalid S. Mohammad, Theresa A. Guise  Cancer Cell 
Figure 2 Signalling downstream of the IL-6 receptor
Macrophages, Immunity, and Metabolic Disease
Regulatory T Cells GATA Have It
Volume 7, Issue 1, Pages 1-11 (July 1997)
Figure 5 TLR-dependent signaling pathways inhibited by glatiramer acetate Myeloid differentiation primary response gene 88 (MyD88) and Toll-IL-1 receptor.
Notch signaling from tumor cells: A new mechanism of angiogenesis
The canonical IFN-γ/JAK/STAT pathway.
TAMpering with Toll-like Receptor Signaling
At 17, In-10's Passion Need Not Inflame
Dietmar M.W. Zaiss, William C. Gause, Lisa C. Osborne, David Artis 
The Regulatory T Cell Transcriptosome: E Pluribus Unum
Presentation transcript:

Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune Diseases  Xiaoyu Hu, Lionel B. Ivashkiv  Immunity  Volume 31, Issue 4, Pages 539-550 (October 2009) DOI: 10.1016/j.immuni.2009.09.002 Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 1 IFN-γ-Induced STAT1 Activation Cycle Mediated by Tyrosine Phosphorylation and Lysine Acetylation Unphosphorylated STAT1 dimers are present in the cytoplasm in an equilibrium state between a parallel and antiparallel configuration of STAT1 subunits. Upon activation of IFNGR signaling, STAT1 is phosphorylated by JAK kinases on tyrosine 701 and phosphorylation stabilizes a parallel dimer configuration that exhibits DNA binding activity. Phosphorylated STAT1 translocates to nucleus, binds to GAS DNA sequences, and activates transcription of STAT1 target genes. Active STAT1 in the nucleus undergoes acetylation on lysines 410 and 413, a process catalyzed by histone acetyltransferases (HATs) such as CBP. Acetylation flags STAT1 for dephosphorylation by the STAT1 phosphatase TCP45; an antiparallel dimer configuration facilitates efficient dephosphorylation and thus deactivation. Dephosphorylated STAT1 shuttles back to cytoplasm, where histone deacetylases (HDACs) such as HDAC3 and possibly Sirtuins deacetylate STAT1 and complete the phosphorylation-acetylation cycle. Deacetylation of STAT1 results in less efficient TCP45-mediated dephosphorylation and thus licenses STAT1 for IFNGR-JAK-mediated tyrosine phosphorylation. Immunity 2009 31, 539-550DOI: (10.1016/j.immuni.2009.09.002) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 2 IFN-γ Signaling Disrupts TLR-Induced Feedback Inhibitory Loops As shown on the left, IFN-γ enhances TLR-induced TNF production by disrupting an IL-10-mediated inhibitory loop. IFN-γ signaling leads to increased activity of GSK3, which negatively regulates Il10 expression by suppressing activation of transcription factors CREB and AP-1. As shown on the right, IFN-γ enhances TLR-induced IL-6 and IL-12 production by disrupting an inhibitory loop mediated by canonical Notch target genes Hes1 and Hey1. IFN-γ signaling downregulates intracellular NICD2 amounts and thus inhibits expression of Hes1 and Hey1. Hes1 and Hey1 are transcription repressors that negatively regulate Il6 and Il12 gene expression. Immunity 2009 31, 539-550DOI: (10.1016/j.immuni.2009.09.002) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 3 Signaling Mechanisms Associated with IFN-γ-Mediated Attenuation of Tissue Destruction IFN-γ suppresses inflammatory tissue destruction via regulation of IL-1R and TLR signaling. IFN-γ inhibits IL-1 signaling and subsequent induction of destructive factors in macrophages by downregulating IL-1RI expression. In addition, IFN-γ blocks induction of MMP downstream of TLR signaling by superinducing transcription repressor ATF3 and inhibiting transcription activators CREB and AP-1. IFN-γ inhibits CREB activity by suppressing its serine phosphorylation and inhibits AP-1 by downregulating nuclear protein levels of its subunits. IFN-γ inhibits osteoclastogenesis and bone resorption via regulation of RANK, CSF-1R, and TREM2 signaling. In osteoclast progenitor cells, IFN-γ suppresses expression as well as signal transduction of RANK, CSF-1R, and TREM2, receptors critical for the process of osteoclastogenesis. IFN-γ also attenuates fibrosis via inhibition of TGF-βR and IL-4R signaling. IFN-γ suppresses TGF-βR signaling by induction of inhibitory SMAD (SMAD7) and by direct inhibition of SMAD3 by STAT1. IFN-γ inhibits IL-4R signaling by induction of SOCS1. Immunity 2009 31, 539-550DOI: (10.1016/j.immuni.2009.09.002) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 4 Signaling Mechanisms Associated with IFN-γ-Mediated Regulation of T Cell Differentiation and Function In Th1 cell differentiation, IFN-γ-STAT1 signaling is critical for induction of T-bet and thus for sustaining the positive feedback loop that leads to heightened production of IFN-γ. IFN-γ blocks Th2 cell differentiation by inhibiting IL-4-STAT6 signaling. IFN-γ and STAT1 also block Th17 cell differentiation. IFN-γ-STAT1 signaling can potently inhibit Th17 cell differentiation, but the mechanism of action is not clear. Because STAT3 signaling from multiple cytokines including IL-6, IL-23, and IL-21 plays a pivotal role in mediating Th17 cell differentiation, it is possible that IFN-γ-STAT1 suppresses Th17 cell by targeting STAT3 (as shown by dotted lines). IFN-γ and STAT1 also inhibit the aryl hydrocarbon nuclear receptor (AHR) important for Th17 cell differentiation, and it is possible that suppression of TGF-β and IL-1 signaling by IFN-γ contributes to inhibition of Th17 cell differentiation (not depicted). IFN-γ further regulates Treg cell differentiation and function. IFN-γ can block TGFβ-mediated Treg cell differentiation. In Foxp3+ Treg cells, IFN-γ upregulates expression of T-bet, which in turns promotes expression of CXCR3 that regulates homing of T-bet+ FoxP3+ Treg cells to sites of Th1 cell inflammation. T-bet also increases suppressive function of Treg cells, and T-bet+ FoxP3+ Treg cells effectively suppress Th1 cell inflammation in vivo. Immunity 2009 31, 539-550DOI: (10.1016/j.immuni.2009.09.002) Copyright © 2009 Elsevier Inc. Terms and Conditions